Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012 by Peking Union Medical College Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Beijing Tiantan Hospital
Tianjin Medical University General Hospital
Information provided by (Responsible Party):
Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT01670890
First received: August 19, 2012
Last updated: August 21, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)